[국제]Japan is in a hurry to vaccination… 50 million people will be given priority from next February

[앵커]

The Japanese government is speeding up the vaccination plan for the entire population.

As early as next February, about 50 million people, including medical workers and the elderly, will be given a priority vaccination, but the recommendation to be careful seems to reflect the sense of crisis that it is no longer possible.

Tokyo Correspondent Lee Kyung-ah reports.

[기자]

In Tokyo, Japan, nearly 900 new confirmed cases came out, again recording the highest daily.

A government analysis that the rate of wearing masks has declined this month while the spread of infection has not subsided.

This means that even if you ask for measures to prevent infection, such as refraining from going out and having dinner, the alertness is not the same as before.

The Japanese government is in a hurry to vaccination, a situation beyond the level that can be prevented by individual efforts.

Starting from February next year, the policy is to promote vaccination in stages for about 50 million people.

[스가 요시히데 / 일본 총리 : 확실히 심사한 뒤에 승인한 백신은 우선 의료 종사자와 고령자부터, 그 다음은 고령자 시설에 종사하는 분들부터 전액 정부 부담으로 접종을 실시할 것입니다.]

People with underlying diseases are also eligible for vaccination.

This includes people with 14 related diseases such as heart disease, kidney disease, and diabetes.

Amid concerns about the effectiveness and safety of the vaccine, Prime Minister Suga’s response, who is the 72-year-old who will be eligible for vaccination this year, is also of interest.

[가토 가츠노부 / 일본 관방장관 : 스가 총리가 이달 4일 기자회견에서 자신에게 순서가 돌아오면 백신을 맞고 싶다고 발언한 바 있어 그런 방향으로 적절히 대응하리라 생각합니다.]

The Japanese government recently revised the relevant law, making it mandatory for all citizens to get the Corona 19 vaccine in their area.

Currently, three vaccine companies, including Pfizer, AstraZeneca, and Modena, have agreed to supply a supply of 145 million people for the entire population.

On the 18th, Pfizer, a US pharmaceutical company, applied for approval for the use of the vaccine in Japan for the first time.

Pfizer’s vaccines are expected to undergo an’emergency approval process’ that significantly shortens the screening period, which normally took more than a year.

This is Kyungah Lee from YTN in Tokyo.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

– .